Banks should treat compliance as a design constraint, not a late-stage blocker. The practical approach is to build controls, reporting, capital planning, and product governance into innovation from the start, then test whether the proposed activity fits liquidity, collateral, and permitted-business rules. That reduces avoidable rework and lets teams identify which experiments are viable before they consume budget or create supervisory friction.
Why compliance and innovation are not opposites
For banks, the real tension is not compliance versus innovation, it is unmanaged innovation versus controlled innovation. New products usually fail when teams treat regulatory duties as paperwork after the business case is approved. The better model is to ask whether the product can operate within the bank’s existing authority, risk appetite, reporting, and funding assumptions before it reaches launch.
That means compliance should shape product design choices, not just final approval. If a product changes liquidity demands, collateral treatment, customer disclosures, or permitted activity boundaries, those effects need to be visible early enough that product, legal, risk, finance, and operations can still change the design rather than merely document the exception.
Well-run banks use this constraint to improve innovation quality. A product that cannot survive legal and prudential review is not a near miss, it is a poor candidate for scale. Early control design also shortens the path from experiment to launch because the bank is not rebuilding governance, reporting, and approval flows at the end of the process.
One useful reference point is that financial firms are increasingly expected to show resilience, third-party control, and product oversight together, not as separate workstreams. For example, DORA ties operational resilience to governance and ICT risk management, while FATF Recommendations remind banks that product innovation can also create AML, customer due diligence, and monitoring obligations.
Where higher-risk products usually break down
Higher-risk products tend to create problems in four places: governance, capital and liquidity treatment, permitted-use boundaries, and monitoring after launch. A product can be innovative but still fail if the bank cannot explain who approved it, what exposure it creates, how losses are absorbed, and what triggers a stop or redesign decision.
Another common failure mode is assuming the control framework for an existing product will transfer cleanly to a new one. In practice, a new lending structure, embedded finance feature, tokenised asset, or API-driven customer journey may change customer classification, settlement timing, fraud exposure, reporting logic, or cross-border obligations. Those are design inputs, not downstream cleanup items.
Banks also underestimate how much innovation depends on clear operating boundaries. If the product relies on external partners, platform dependencies, or rapid release cycles, then control evidence, issue escalation, and exception handling must work at the same speed as the product team. Otherwise, the bank gets either delayed launches or silent risk accumulation.
- Set approval gates around business model changes, not just code or user interface changes.
- Require the product owner to show how the activity fits liquidity, collateral, reporting, and conduct rules.
- Build monitoring for threshold breaches, not just monthly review packs.
- Define the kill switch or redesign trigger before pilots begin.
Practitioner guidance for designing compliant innovation
What to prioritise: Start with the control questions that determine whether the idea is legally and operationally viable, then move to customer experience and growth potential. If the product depends on unresolved treatment of capital, safeguarding, disclosure, or third-party dependency, it is not ready for scale even if the prototype works.
What to verify: The bank should be able to produce a clear decision record showing who owns the product, what rules were tested, which assumptions were accepted, and which limits apply in production. If the answer relies on informal agreement or a future remediation plan, the launch is carrying hidden regulatory debt.
What practitioners underestimate: Innovation risk is often cumulative. Several small exceptions can become one large governance failure when the product reaches volume, new jurisdictions, or partner dependence. The objective is not to slow every experiment, it is to make sure the bank knows which experiments can safely become products.
Practitioner takeaway: The strongest banks do not ask compliance to approve innovation after the fact, they use compliance to separate viable ideas from expensive ones before commitment, so novelty never outruns control.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST CSF 2.0 set the technical controls, while DORA define the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| DORA | ICT risk management and digital operational resilience — ICT Risk Management and Resilience | Banks need resilience controls for new products with operational and third-party risk. |
| Recommendation — Embed product governance, resilience testing, and ICT risk oversight before launch. | ||
| NIST CSF 2.0 | GV.1 — Organizational Context | Innovation must fit the bank’s mission, authority, and risk appetite. |
| Recommendation — Define governance boundaries and risk appetite before approving experimental products. | ||
Related resources from NHI Mgmt Group
- Why do compliance failures create operational and financial risk for security teams?
- Why do non-human identities create compliance risk even when policies exist?
- When do service accounts become a higher risk than ordinary user accounts?
- Why do AI tools create new compliance risk for financial data access?
